ArticleOncology letters2021

A combination of sorafenib and radiotherapy reduces NF-κB activity and growth of hepatocellular carcinoma in an orthotopic mouse model.

Hui-Yen Chuang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.